Codes / ICD10CM / D22.39

D22.39 Melanocytic nevi of other parts of face

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Melanocytic Nevi of Other Parts of Face (D22.39)

Name of the Condition

  • Melanocytic Nevi of Other Parts of Face: Benign pigmented growths on the face, excluding specified areas like the lip. These are commonly referred to as moles and are typically harmless but may require monitoring for changes.

Summary

Melanocytic nevi are benign proliferations of melanocytes, the pigment-producing cells in the skin. When located on other parts of the face (excluding specified areas), they are classified under ICD-10-CM code D22.39. These growths appear as pigmented spots or lesions and are generally asymptomatic. While usually harmless, they should be observed for changes that could indicate malignancy.

Causes

The development of melanocytic nevi is primarily influenced by genetic factors and exposure to ultraviolet (UV) radiation. Hormonal changes, such as those during puberty or pregnancy, may also contribute to their formation.

Risk Factors

  • Genetic predisposition (family history of moles or melanoma)
  • Fair skin type with susceptibility to sunburns
  • Frequent exposure to UV radiation
  • A large number of moles present on the skin

Symptoms

  • Visible dark spots or patches on the face
  • Moles can be flat or raised, with a smooth or rough texture
  • Typically asymptomatic, but changes in size, shape, or color warrant attention

Diagnosis

Diagnosis begins with a visual examination by a healthcare provider. Dermoscopy, a magnified skin surface analysis, may be used to assess features. A biopsy may be conducted if there is suspicion of malignancy.

Treatment Options

  • Observation: Many facial nevi require no treatment unless cosmetic concerns arise.
  • Surgical removal: If a mole changes suspiciously, it may be excised for histopathological evaluation.
  • Laser therapy: May be considered for cosmetic removal, though not for diagnostic purposes.

Prognosis and Follow-Up

Most melanocytic nevi are benign and have an excellent prognosis. Regular follow-up is recommended to monitor for changes in size, shape, or color, which could indicate malignancy. Patients should be educated on self-examination and report any concerning changes promptly.

Complications

While rare, complications can include cosmetic concerns or, in very rare cases, malignant transformation into melanoma. Early detection and monitoring reduce these risks.

Lifestyle & Prevention

  • Use broad-spectrum sunscreen with SPF 30 or higher.
  • Wear protective clothing and seek shade during peak sun hours.
  • Avoid tanning beds and excessive sun exposure.
  • Perform regular self-examinations of the skin.

When to Seek Professional Help

Seek medical attention if a mole shows changes in size, shape, color, or texture, or if it becomes painful, itchy, or bleeds. New or rapidly appearing moles should also be evaluated.

Tips for Medical Coders

Document the specific location of the nevi on the face (e.g., cheek, forehead) to support the use of D22.39. Ensure clinical documentation aligns with the code's specificity, avoiding vague terms like "face" without further detail. Verify that the lesion is confirmed as benign and not associated with malignancy, as this impacts coding accuracy.

Book a walkthrough

D22.39 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.